Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Histological Evaluation of Hard Tissue Formation After Direct Pulp Capping With RetroMTA (RetroMTA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03631511
Recruitment Status : Completed
First Posted : August 15, 2018
Last Update Posted : August 15, 2018
Sponsor:
Information provided by (Responsible Party):
Alicja Nowicka, Pomeranian Medical University Szczecin

Brief Summary:
This study presents a clinical and histological evaluation of human pulp tissue responses after direct capping using RetroMTA. Seven teeth were subjected to pulp exposure, direct capping with RetroMTA, and restoration with a composite resin. Seven months later, the teeth were clinically and radiographically evaluated. The teeth were then extracted and subjected to histological processing and evaluation.

Condition or disease Intervention/treatment Phase
Dental Pulp Exposure Procedure: direct pulp capping with RetroMTA Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 3 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Histological Evaluation of Direct Pulp Capping on Human Pulp Tissue Using a RetroMTA
Actual Study Start Date : April 3, 2016
Actual Primary Completion Date : March 20, 2017
Actual Study Completion Date : June 18, 2018

Arm Intervention/treatment
Experimental: RetroMTA
Direct pulp capping with RetroMTA (BioMTA, Daejeon, Korea)
Procedure: direct pulp capping with RetroMTA
The study included seven caries-free third molars from three adults. These teeth were subjected to pulp exposure, direct capping with RetroMTA, and restoration with a composite resin. Seven months later, the teeth were clinically and radiographically evaluated. The teeth were then extracted and subjected to histological processing and evaluation.




Primary Outcome Measures :
  1. Histological Evaluation of Direct Pulp Capping on Human Pulp Tissue Using a RetroMTA [ Time Frame: 7 months ]

    Each histomorphologic section was scored from 1-3, with 1 representing the most desired result and 3 representing the least desired result.

    Mineralized tissue bridge

    1. Complete
    2. Incomplete
    3. Absent

    Mineralized tissue morphology

    1. Dentin associated with irregular hard tissue
    2. Only irregular hard tissue deposition
    3. No hard tissue deposition

    Inflammatory response

    1. Absent
    2. Mild (inflammatory cells next to dentin bridge or area of pulp exposure only)
    3. Severe (all of the coronal pulp is infiltrated or necrotic)

    Odontoblastic cell layer

    1. Presence of odontoblast cells and odontoblast-like cells
    2. Presence of odontoblast-like cells only
    3. Absent

    Presence of bacteria

    1. Absence
    2. Presence of stained bacterial profiles along the coronal or apical walls
    3. Presence of stained bacterial profiles within the dental pulp


Secondary Outcome Measures :
  1. Clinical Examination of Direct Pulp Capping on Human Pulp Tissue Using a RetroMTA [ Time Frame: 7 months ]

    Number of participants with adverse events related to RetroMTA treatment

    Periapical pathology

    1. absent
    2. present

    The presence of pain

    1. absent
    2. present

    Tooth sensitivity:

    I. Reactions to thermal stimuli

    1. present
    2. absent

    II. Electric sensitivity

    1. present
    2. absent

    1 representing the most desired result and 2 representing the least desired result.




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   30 Years to 37 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • The inclusion criteria were healthy patients with no contributing systemic conditions, who had at least one caries-free mature permanent third molar

Exclusion Criteria:

  • The exclusion criteria included patients who had pulp inflammation, pulp necrosis, root resorption or periapical diseases

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03631511


Locations
Layout table for location information
Poland
Pomeranian Medical University in Szczecin
Szczecin, Rybacka 1, Poland, 70-111
Sponsors and Collaborators
Pomeranian Medical University Szczecin
Investigators
Layout table for investigator information
Study Director: Alicja Nowicka, DDS, PhD Department of Conservative Dentistry and Endodontics, Pomeranian Medical University, Al. Powstańców Wielkopolskich 72, 70-111, Szczecin, Poland
Study Chair: Till Dammaschke, DDS, PhD Department of Periodontology and Operative Dentistry, Westphalian Wilhelms-University, Albert-Schweitzer-Campus 1, building W 30, 48149 Münster, Germany
Study Chair: Mariusz Lipski, DDS, PhD Department of Preclinical Conservative Dentistry and Preclinical Endodontics, Pomeranian Medical University, Al. Powstańców Wielkopolskich 72, 70-111, Szczecin, Poland
Study Chair: Domenico Ricucci, MD, DDS Private Practice, Piazza Calvario, 7, 87022 Cetraro (CS), Italy
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Alicja Nowicka, DDS, PhD Alicja Nowicka, Pomeranian Medical University Szczecin
ClinicalTrials.gov Identifier: NCT03631511    
Other Study ID Numbers: Direct capping RetroMTA
First Posted: August 15, 2018    Key Record Dates
Last Update Posted: August 15, 2018
Last Verified: August 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Alicja Nowicka, Pomeranian Medical University Szczecin:
direct pulp capping, RetroMTA, histological evaluation
Additional relevant MeSH terms:
Layout table for MeSH terms
Dental Pulp Exposure
Dental Pulp Diseases
Tooth Diseases
Stomatognathic Diseases